1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Sarcomatoid Renal Cell Carcinoma: new trials by email Literature Review of Sarcomatoid Renal Cell Carcinoma trials Research Report on Sarcomatoid Renal Cell Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase II Sequential Treatment Trial of Single Agent Nivolumab, Then Combination Ipilimumab + Nivolumab in Metastatic or Unresectable Non-Clear Cell Renal Cell Carcinoma (ANZUP1602) Nivolumab, Ipilimumab - Renal Cell Carcinoma, Papillary Renal Cell Carcinoma Type 1 | Phase 2 | Unknown | Australian and New Zealand Urogenital and Prostate Cancer Trials Group | 85 | 2017-10-19 | 2022-02-16 |
Adenocarcinoma (1) · Carcinoma (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Kidney Diseases (1) · Kidney Neoplasms (1) · Male Urogenital Diseases (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Glandular and Epithelial (1) · Urogenital Diseases (1) · Urogenital Neoplasms (1) · Urologic Diseases (1) · Urologic Neoplasms (1)
Ipilimumab (1) · Nivolumab (1)
Australian and New Zealand Urogenital and Prostate Cancer Trials Group (1)
Australia (1)